Petco Health Wellness Company Inc
For the period ended Nov 2, 2024. Filed Dec 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Nov 2, 2024 · Filed Dec 6, 2024
WOOF$2.96-0.7%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Equity
| Common stock | ||||||||
|---|---|---|---|---|---|---|---|---|
| Class A (shares) | Class B-1 (shares) | Class B-2 (shares) | Amount | Additional paid-in capital | Accumulateddeficit | Accumulatedothercomprehensiveincome (loss) | Totalstockholders’equity | |
| Balance at February 3, 2024 | 231,156 | 37,791 | 37,791 | $269 | $2,229,582 | $(1,047,243) | $1,821 | $1,184,429 |
| Equity-based compensation expense (Note 7) | — | — | — | — | 17,451 | — | — | 17,451 |
| Net loss | — | — | — | — | — | (46,483) | — | (46,483) |
| Foreign currency translation adjustment, net of tax | — | — | — | — | — | — | 1,665 | 1,665 |
| Unrealized gain on derivatives (Note 5), net of tax | — | — | — | — | — | — | 6,372 | 6,372 |
| Gains on derivatives reclassified to income (Note 5), net of tax | — | — | — | — | — | — | (850) | (850) |
| Issuance of common stock, net of tax withholdings | 1,793 | — | — | 2 | (277) | — | — | (275) |
| Balance at May 4, 2024 | 232,949 | 37,791 | 37,791 | $271 | $2,246,756 | $(1,093,726) | $9,008 | $1,162,309 |
| Equity-based compensation expense (Note 7) | — | — | — | — | 11,879 | — | — | 11,879 |
| Net loss | — | — | — | — | — | (24,823) | — | (24,823) |
| Foreign currency translation adjustment, net of tax | — | — | — | — | — | — | (10,921) | (10,921) |
| Unrealized loss on derivatives (Note 5), net of tax | — | — | — | — | — | — | (7,848) | (7,848) |
| Gains on derivatives reclassified to income (Note 5), net of tax | — | — | — | — | — | — | (862) | (862) |
| Issuance of common stock, net of tax withholdings | 2,878 | — | — | 3 | 1,746 | — | — | 1,749 |
| Balance at August 3, 2024 | 235,827 | 37,791 | 37,791 | $274 | $2,260,381 | $(1,118,548) | $(10,623) | $1,131,484 |
| Equity-based compensation expense (Note 7) | — | — | — | — | 11,330 | — | — | 11,330 |
| Net loss | — | — | — | — | — | (16,673) | — | (16,673) |
| Foreign currency translation adjustment, net of tax | — | — | — | — | — | — | (7,198) | (7,198) |
| Unrealized gain on derivatives (Note 5), net of tax | — | — | — | — | — | — | 5,127 | 5,127 |
| Gains on derivatives reclassified to income (Note 5), net of tax | — | — | — | — | — | — | (574) | (574) |
| Issuance of common stock, net of tax withholdings | 1,331 | — | — | 1 | (659) | — | — | (658) |
| Balance at November 2, 2024 | 237,158 | 37,791 | 37,791 | $275 | $2,271,052 | $(1,135,221) | $(13,268) | $1,122,838 |
| Common stock | ||||||||
|---|---|---|---|---|---|---|---|---|
| Class A (shares) | Class B-1 (shares) | Class B-2 (shares) | Amount | Additional paid-in capital | Retained earnings (Accumulated deficit) | Accumulatedothercomprehensive(loss) income | Totalstockholders’equity | |
| Balance at January 28, 2023 | 228,338 | 37,791 | 37,791 | $266 | $2,152,342 | $232,967 | $(4,098) | 2,381,477 |
| Equity-based compensation expense (Note 6) | — | — | — | — | 22,282 | — | — | 22,282 |
| Net loss | — | — | — | — | — | (1,892) | — | (1,892) |
| Foreign currency translation adjustment, net of tax | — | — | — | — | — | — | 1,057 | 1,057 |
| Unrealized loss on derivatives (Note 4), net of tax | — | — | — | — | — | — | (984) | (984) |
| Losses on derivatives reclassified to income (Note 4), net of tax | — | — | — | — | — | — | 433 | 433 |
| Issuance of common stock, net of tax withholdings | 727 | — | — | 1 | (1,254) | — | — | (1,253) |
| Balance at April 29, 2023 | 229,065 | 37,791 | 37,791 | $267 | $2,173,370 | $231,075 | $(3,592) | $2,401,120 |
| Equity-based compensation expense (Note 7) | — | — | — | — | 24,322 | — | — | 24,322 |
| Net loss | — | — | — | — | — | (14,606) | — | (14,606) |
| Foreign currency translation adjustment, net of tax | — | — | — | — | — | — | 1,107 | 1,107 |
| Unrealized gain on derivatives (Note 4), net of tax | — | — | — | — | — | — | 3,915 | 3,915 |
| Losses on derivatives reclassified to income (Note 4), net of tax | — | — | — | — | — | — | 361 | 361 |
| Issuance of common stock, net of tax withholdings | 761 | — | — | 1 | (1,457) | — | — | (1,456) |
| Balance at July 29, 2023 | 229,826 | 37,791 | 37,791 | $268 | $2,196,235 | $216,469 | $1,791 | $2,414,763 |
| Equity-based compensation expense (Note 7) | — | — | — | — | 18,678 | — | — | 18,678 |
| Net loss | — | — | — | — | — | (1,241,137) | — | (1,241,137) |
| Foreign currency translation adjustment, net of tax | — | — | — | — | — | — | 407 | 407 |
| Unrealized gain on derivatives (Note 5), net of tax | — | — | — | — | — | — | 2,628 | 2,628 |
| Gains on derivatives reclassified to income (Note 5), net of tax | — | — | — | — | — | — | (286) | (286) |
| Issuance of common stock, net of tax withholdings | 467 | — | — | — | (2,200) | — | — | (2,200) |
| Balance at October 28, 2023 | 230,293 | 37,791 | 37,791 | $268 | $2,212,713 | $(1,024,668) | $4,540 | $1,192,853 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.